The application of clinical smart nanocarriers continues to be a fruitful and challenging field for both academic and clinical disciplines as well as industries. These clinically approved micro- and nanobased products have impacted treatment of numerous predominant diseases including cancer, diabetes, and different immune disorders. This Two-Volume Set presents a comprehensive overview of the most recent studies on smart micro- and nanomaterials with a focus on their smart activity for formation of targeted and responsive drug-delivery carriers and pharmaceutical applications.
This wide-ranging reference work is written to support researchers in the fields of materials engineering and biotechnology with the goal of improving the diagnosis and treatment of disease and patient quality of life.